Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 871-880 of 1772 for

Edit search filters
  1. Phase 3 Trial Of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment Of Advanced Renal Cell Carcinoma (RCC)

    Scottsdale/Phoenix, AZ

  2. Prospective Study To Compare The Efficacy Of E.G.Scan To Detect Barrett's Esophagus Compared With Standard Endoscopy

    Rochester, MN

  3. Ipilimumab With Or Without Talimogene Laherparepvec In Unresected Melanoma

    Jacksonville, FL

  4. A Study To Evaluate MEDI2228 In Subjects With Relapsed/ Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Trial Of The FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered As Maintenance Therapy Following Allogeneic Transplant For Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine As First-Line Treatment For Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), Or Low-Blast Acute Myelogenous Leukemia (AML)

    Jacksonville, FL

  7. A Study To Evaluate The Effectiveness And Safety Of Panzyga In Patients With Chronic Lymphocytic Leukemia

    Rochester, MN

  8. Oral Tamoxifen Vs. TamGel Vs. Control In Women With Atypical Hyperplasia Or Lobular Carcinoma In Situ

    Rochester, MN

  9. Testing The Addition Of MEDI4736 (Durvalumab) To Chemotherapy Before Surgery For Patients With High-Grade Upper Urinary Tract Cancer

    Jacksonville, FL, Rochester, MN

  10. A Study To Evaluate Trabectedin With Olaparib In Advanced Unresectable Or Metastatic Sarcoma

    Rochester, MN

.

Mayo Clinic Footer